The Outcome of Repeated In Vitro Fertilization-Embryo Transfer Based on the Endometrial Thickness



Similar documents
The effect of endometrial thickness on IVF/ICSI outcome

Article. Laura Detti, MD, Frank D. Yelian, MD, PhD, Michael L. Kruger, MA, Michael P. Diamond, MD, Elizabeth E. Puscheck, MD

Welcome to chapter 8. The following chapter is called "Monitoring IVF Cycle & Oocyte Retrieval". The author is Professor Jie Qiao.

Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound

Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome

Martha Luna, M.D., a,b Lawrence Grunfeld, M.D., a,b Tanmoy Mukherjee, M.D., a,b Benjamin Sandler, M.D., a,b and Alan Barry Copperman, M.D.

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection

The objectives of this chapter are: To provide an understanding of the various stimulation protocols used in IVF To enable the student to understand

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG.

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY

The Menstrual Cycle. Model 1: Ovarian Cycle follicular cells

Assisted Reproductive Technologies at IGO

How do fertility drugs work?

In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval

Clinical Study Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries

Understanding Blood Tests - Pregnancy/Fertility Monitoring by Beth Anne Ary M.D

Research Article Association of ABO Blood Type and Ovarian Stimulation Response in Oocyte Donors

Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc., M.D.

Unit 3 REPRODUCTIVE SYSTEMS AND THE MENSTRUAL CYCLE

Artificial insemination with donor sperm

In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic

Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan

The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test".

Ehlers-Danlos Syndrome Fertility Issues. Objectives

Fertility care for women diagnosed with cancer

Jerry A. Sims, M.D., F.A.C.O.G. Reproductive Endocrinology & Infertility

In - Vitro Fertilization Handbook

Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome

1. AMOUNT OF FSH PRESENT

The Menstrual Cycle, Hormones and Fertility Treatment

Informed Consent Packet - In Vitro Fertilization (IVF)

in vitro fertilization outcome in women with endometriosis & previous ovarian surgery

ARTICLE IN PRESS CONTROVERSY: ACUPUNCTURE

In Vitro Fertilization (IVF) Page 1 of 11

In Vitro Fertilization

SPONTANEOUS AND PHARMACOLOGICALLY INDUCED REMISSIONS IN PATIENTS WITH PREMATURE OVARIAN FAILURE

Project proposal. Reproductive tourism in India: A description of surrogate mothers and their offspring. Medical student Malene Tanderup Kristensen

Director, IVF Program, Division of Reproductive Endocrinology & Infertility

Clinical Study Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve

Luteal phase support in in-vitro fertilization

Artificial insemination

Consultations & other investigations

One thousand initiated cycles of in vitro fertilization in women >40 years of age

Lesbian Pregnancy: Donor Insemination

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?

Hormonal Oral Contraceptives: An Overview By Kelsie Court. A variety of methods of contraception are currently available, giving men and

Endocrinology of the Female Reproductive Axis

Impact of hypnosis during embryo transfer on the outcome of in vitro fertilization embryo transfer: a case-control study

Patient Information: Endometriosis Disease Process and Treatment

Technological & Ethical Issues In Laboratory-Assisted Reproduction A Short History to Accompany the Lecture

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions

Original Article Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteria

Management fertility sparing degli endometriomi Errico Zupi

CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM

How To Get A Refund On An Ivf Cycle

MINISTRY OF HEALTH Quality and Service Administration. Fe r t i l i z at i o n. to I n - V i t r o. G u i d e. i n I s r a e l

CYCLE EVALUATION. Please review this guide carefully. I. Early In Cycle. A. Selection of the Dominant Follicle (~ Day 3)

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY

Drug Therapy Guidelines: Injectable Fertility Medications

IN VITRO FERTILIZATION (IVF) GAMETE INTRAFALLOPIAN TRANSFER (GIFT)

Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)

Anatomy and Physiology of Human Reproduction. Module 10a

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER

RYAN G. STEWARD, M.D. HOUSTON FERTILITY INSTITUTE MEDICAL CENTER WOODLANDS CORPORATE

Timing is everything. Ovulation Tracking. Patient Information Booklet

In vitro fertilisation (IVF) & intra-cytoplasmic sperm injection (ICSI)

NON MEDICARE FEES CANBERRA FERTILITY CENTRE VERSION JANUARY 2015 AM QWB 295

Egg Donation Process, Risk, Consent and Agreement

Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES

Outline. Objective(s) Background. Methods. Results. Discussion. Questions

In Vitro Fertilization and Severe Male Infertility - A Comparison of Two Facilies

EFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study

Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization

Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome

Emmett F. Branigan, MD,* Antoinette Estes, BS, Kenneth Walker, BS, Jillian Rothgeb, BS. Bellingham IVF and Infertility Center, Bellingham, WA

Original Article Patients with polycystic ovary syndrome have successful embryo arrest

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN (651)

GYNAECOLOGY. Ahmed Mohamed Abbas*, Mohamed Khalaf*, Abd El-Aziz E. Tammam**, Ahmed H. Abdellah**, Ahmed Mwafy**. Introduction ABSTRACT

The IUI procedure Who should consider an IUI IUI success rates IUI cost What to consider if IUI is unsuccessful. The IUI procedure:

KUTTEH KE FERTILITY ASSOCIATES OF MEMPHIS, PLLC AND MEMPHIS FERTILITY LABORATORY, INC.

Reduced Ovarian Reserve Is there any hope for a bad egg?

OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies

Original Article The impact of endometriosis on IVF/ICSI outcomes

Consent for In Vitro Fertilization

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

POLYCYSTIC OVARY SYNDROME

Fertility Treatment Cost

SO, WHAT IS A POOR RESPONDER?

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES

ICSI and Miscarriage - A Review

Risks and complications of assisted conception

REPRODUCTIVE ENDOCRINOLOGY

Reproduction and its Hormonal Control

European IVF Monitoring (EIM) Year: 2010

IVF Centrum, AZ Jan Palfijn Hospital, Henri Dunantlaan 5, 9000 Gent, Belgium.

CONTROVERSY: VALUE OF THE DAY 3 FSH MEASUREMENT

Can quantitative three-dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome?

Transcription:

Bulletin of the Osaka Medical College 49 1, 2 5-9, 2003 5 Original Article The Outcome of Repeated In Vitro Fertilization-Embryo Transfer Based on the Endometrial Thickness Yoshiki YAMASHITA, Toshimitsu HOSOTANI, Syoko MORISHIMA, Kuniko MORI, Takahisa USHIROYAMA and Minoru UEKI Department of Obstetrics and Gynecology, Osaka Medical College, Takatsuki, Osaka, Japan Key Words : endometrial thickness, IVF-ET, serum estradiol, ABSTRACT Objective: To determine whether in vitro fertilization embryo transfer (IVF-ET) outcome is affected by endometrial thickness. Design: Retrospective study. Setting: IVF-ET unit in Osaka Medical College. Patients: Twenty-eight patients with tubal infertility who became pregnant following IVF-ET between 1998-2000. All patients underwent 2 cycles of IVF-ET with long down-regulation protocol of Gonadotorophin releasing hormone analogue (GnRHa) and became pregnant following one of them. These fifty-six courses were divided into pregnant and non-pregnant courses. Main Outcome Measure(s): Endometrial thickness, serum E2 and LH levels, number of oocytes, fertilization rate, cleavage rate, high quality embryo rate and pregnancy rate were investigated. Results: The endometrium in the pregnant courses were thicker than those in the non-pregnant courses (P<0.05). Serum E2 level showed direct correlation with endometrial thickness (R=0.882, P < 0.001). The courses with endometrial thickness greater than or equal to 10 mm showed a significantly higher pregnancy rate than courses with endometrium of less than 10 mm. Although there was no statistical difference in high-quality embryo rate or number of transferred embryo rate between the two groups, the fertilization rate of the courses with endometrium greater than or equal to 10 mm was higher than that in the courses with endometrium less than 10 mm. Conclusion: Although the number of transferred embryos and embryo quality does not affect the pregnancy rate, endometrial thickness might play an important role in the success of IVF-ET. Introduction During the menstrual cycle the endometrium shows cyclic change for implantation based on change of estaradiol in the proliferative phase and progesterone in the secretory phase. Therefore, certain endometrial abnormalities such as Asherman's syndrome prevent the endometrium from changing normally. Several authors have evaluated the effect of endometrial thickness during the pre-ovulatory phase on pregnancy outcome during in vitro fertilization embryo transfer (IVF-ET), but the results have been controversial (CHECK et al, 1991; DICKEY et al., 1997; NOYES et al., 1995; RINALDI et al., 1996; SHIELD et al., 2001). For example, some authors have supposed the existence of a correlation between the degree of endometrial development as determined by ultra- 5

6 Y. YAMASHITA, T. HOSOTANI, K. MORI, T. USHIROYAMA, M. UEKI sound and the probability of embryo implantation (CHECK et al, 1991; DICKEY et al., 1992; NOYES et al., 1995; RINALDI et al., 1996), while others have not supported these findings (De GEYTER et al., 2000; SHIELD et al., 2001). The measurement of endometrial thickness is a simple technique, however, it is still controversial whether endometrial thickness determined by ultrasound-examination is a useful parameter to predict IVF-ET outcome (KHALIFA et al., 1992). The differences of regime and profile of each patient might be a cause of these controversies, therefore, we investigated the difference of endometrial thickness in pregnant and non-pregnant cycle of IVF-ET in the patients who underwent 2 courses of IVF-ET and became pregnant following one of them. Material and Method Patients The medical records of 28 patients with tubal infertility undergoing IVF-ET in the program at Osaka Medical College during 1998 and 2000 were retrospectively reviewed. All patients underwent 2 cycles of IVF-ET with long down-regulation protocol of Gonadotorophin releasing hormone analogue (GnRHa) and became pregnant following one of them. The cycles, 56 in total were divided into pregnant and non-pregnant cycles. Protocol of controlled ovarian hyperstimulation (COH) Treatment with the GnRHa was started in the mid-luteal phase of the preceding cycle and was continued through the follicular phase of the next cycle until the day of hcg administration. Protocol of controlled ovarian hyperstimulation (COH) with hmg (150 IU FSH and 150 IU LH per ampoule; Pergonal; Teizou Pharma. Co. Tokyo, Japan) and/or FSH (75 IU FSH per ampoule; Phertinom; Serono, Welwyn Garden City, Herts, UK) was started on day 3 of the current cycle in an individual step-down protocol until a dominant follicle reached a diameter of 18 mm. Ovulation was triggered with 10,000 IU of hcg (Pregnyl; Organon, Cambridge, UK), which was administered 35 hours before oocyte retrieval. Follicular maturation and endometrial thickness were monitored by tarnsvaginal ultrasound examination (Sonovista- EX; Mochida, Tokyo, Japan) from day 6 to the day of hcg-administration. Endometrial thickness was measured in the saggital plane with a 7.5-MHz scan at a distance between the hyperechogenic The assessments of endometrial thickness was measured in the saggital plane with a 7.5-MHz scan, and the distance of approximately 1 cm from uterine fundus at the time of hcg injection. Oocyte retrieval was performed via an ultrasoundguided transvaginal approach 35 hours after hcg administration. Insemination was performed with insemination medium (human tubal factor; Life Technologies, Inc., Grand Island, NY, USA) supplemented with 10% synthetic serum substitute (SSS; Irvine Scientific, Santa Ana, CA, USA) 6 hours after oocyte retrieval, and fertilization was confirmed by identification of pronuclei 16 hours after insemination. All embryos were transferred into growth medium (20% SSS + human tubal factor) and were evaluated using the Veeck criteria (VEEK. 1988). Forty-eight hours after oocyte retrieval, embryos in transfer medium (50% SSS + human tubal factor) were implanted into the uterine cavity, and the recipient then rested in bed for 4 hours. Vaginal progesterone suppositories (200 mg/day) was started on the day of oocyte retrieval to provide luteal support and was continued daily until a pregnancy test was performed. Pregnancy was confirmed by identification of an intrauterine gestational sac by transvaginal ultrasound examination. Informed consent was obtained for all tests from controls and patients after the study protocol had been approved by a local ethics committee of Osaka Medical College. Hormone assay Hormonel assay was carried out using commercially available RIA kits. At the time of hcg-injection, E2, P, and LH levels in the serum were assayed to determine whether IVF-ET should be progressed. When LH exceeded 10 IU/l before oocyte retrieval, IVF-ET was canceled. Whether there is any correlation between E2 level and endometrial thickness was investigated. Statistical analysis The significance of difference was determined with unpaired t test and 2 test. A level of P < 0.05 was accepted as statistically significant. Results Table 1 represents hormone environment and endometrial thickness at the time of hcg injection in the pregnant and non-pregnant courses. There was no statistical difference in total dose of hmg/fsh and P, however serum E2 levels in the non-pregnant courses were statistically higher 6 Bulletin of the Osaka Medical College 49 1, 2 5-9, 2003

Endometrial thickness in IVF-ET 7 Table 1 Hormone environment and endometrial thickness at hcg injection of both groups Table 2 IVF-ET outcome based on thickness less than or greater than / equal to 10 mm Fig. 1 Correlation between serum E2 level and endometrial thickness is shown. (Correlation coefficient, 0.865, P<0.001). Fig. 2 Endometrial thickness was divided into 5 groups as shown in X-axis. The Y-axis on the left indicates the number of courses. The open bar represents the number of pregnant couses and the shaded bar represents that of non-pregnant courses. Statistical difference in pregnancy rate was found between endometrial thickness <10 mm and >10 mm (P = 0.035). Bulletin of the Osaka Medical College 49 1, 2 5-9, 2003 7

8 Y. YAMASHITA, T. HOSOTANI, K. MORI, T. USHIROYAMA, M. UEKI than those in the pregnant courses. Moreover, endometrial thickness in the pregnant courses was statistically thicker compared with that in nonpregnant courses (P = 0.000014) (Table. 1). Correlation between serum E2 level and endometrial thickness in the 56 courses is shown in Fig. 1 (correlation coefficient, R=0.865, P<0.001). Endometrial thickness was divided into 5 groups as shown in Fig. 2 and it shows a statistical difference in pregnancy rates between endometrial thickness less than 10 mm and greater than or equal to 10 mm (P = 0.035). Table 2 shows IVF- ET outcome based on endometrial thickness less than 10mm and greater than or equal to 10 mm. Although there was no statistical difference in serum E2 levels, number of picked up oocyte, high-quality embryo rate and number of transferred embryos, fertilization rates and pregnancy rates with endometrial thickness greater than or equal to 10 mm were statistically higher than those with endometrial thickness less than 10mm. No patient experienced ovarian hyperstimulation syndrome (OHSS). Discussion Ultrasonography is a non-invasive method that can provide serial information about the characteristics of the endometrium. The ultrasonographic evaluation of the endometrium varies in terms of thickness and echogenicity throughout the natural or stimulated cycle. The present study was a retrospective study that examined the difference of endometrial thickness of the same patients who underwent IVF-ET twice and became pregnant following the treatments to determine what impact endometrial thickness has on IVF-ET outcome. Controversy exists regarding the prognostic significance of endometrial thickness and pattern regarding the initiation of pregnancy in infertile women whose cycles are monitored by transvaginal sonography. Some authors have reported that not only endometrial thickness but also pattern contribute to outcome of treatment cycle (CHECK et al, 1991; KHALIFA et al., 1992; DICKEY et al., 1997; SHIELD et al., 2001), however an increased luteal phase progesterone secretion might influence endometrial thickness, and various measurement methods (including outer edge to outer edge, and outer edge to inner edge) could further affect the outcome. The use of various measuring methods of endometrial thickness might provide a further explanation for conflicting results. Some authors reported results by cut-off values (DICKEY et al., 1992; NOYES et al., 1995; RINALDI et al., 1996), while others evaluated by mean endometrial thickness or compared endometrial thickness within percentile group (DICKEY et al., 1992; YUVAL et al., 1999). Therefore, in the present study we focused on only endometrial thickness and evaluated it by mean endometrial thickness. Reuter et al. reported that no patient conceived with endomterial thickness <8mm (REUTER et al., 1996) and Bergh et al. found that pregnancies did not occur in patients with an endometrial thickness of <9mm (BERGH et al., 1992). Moreover, Khalifa et al. scrutinized the link between conception and endometrial thickness in IVF-ET and reported a minimal endometrial thickness associated with conception as being 7 mm on the day of hcg and the day of embryo transfer (KHALIFA et al., 1992). In the present study, pregnancy rate of treatment cycle with endometrial thickness <8mm was 1.7% (1/56), therefore, thicker endometrium >10mm might be a useful parameter to predict successful implantation. Previous studies found that there was a positive correlation between endometrial thickness and successful implantation, as well as between endometrial thickness and serum E2 (REMOHI et al., 1997). Kovacs reported pregnancy rates were shown to be higher when endometrial development was one of the factors that played a significant role and other variables such as age embryo quality, number of embryos transferred and stimulation protocol were also shown to have a significant impact on the outcome (KOVACS et al., 2003). On the other hand, four successful pregnancies in patients with endometrium <7mm and one successful pregnancy in spite of 4mm endometrium have been reported (SUNDSTORM et al., 1998; GEYTER et al., 2000). Therefore, reduced endometrial thickness has a marginal effect on the probability of achieving a pregnancy with assisted reproduction. Furthermore, thin endometrium may be associated with pathologic abnormalities such as squamous cell metaplasia (RUIZ-VALASCO et al., 1997), and the endometrium of patients with this abnormality does not show a normal proliferative response to the rising E2 levels (GEYTER et al., 2000). Friedler et al. stated that the low predictive value of endometrial thickness might be explained by its weak relationship with uterine receptivity (FRIEDLER et al., 1996). These data are partially consistent with our results that E2 levels were significantly higher in non-pregnant courses than pregnant ones. 8 Bulletin of the Osaka Medical College 49 1, 2 5-9, 2003

Endometrial thickness in IVF-ET 9 In conclusion, the results of the present study identified a statistically significant difference in mean endometrial thickness between cycles that became preganant and those did not. Endometrial thickness >10mm at the time of hcg administration might be a predictable value for implantation in IVF-ET, however, what affect the endometrial thickness has was undetermined. Further studies including histological examination are required to evaluate what factors affect endometrial development. Acknowledgement We thank Kumiko Sato, Miwako Yamaguchi and other staff members for their technical assistance. Reference BERGH C, HILLENSJO T, NILLSON L. Sonographic evaluation of the endometrium in in vitro fertilization IVF cycles. Acta Obstet Gynecol Scand 71: 624-625, 1992. CHECK JH, NOWROOZI K, CHOE L, LURIE D, DIET- TERICH C. The effect of endometrial thickness and echogenic patterns on pregnancy rates during in vitro fertilization. Fertil Steril 56:1173-1175, 1991. Dickey RP, Olar TT, Curole DN, Taylor SN, Rye PH. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod 7: 418-421, 1997. FRIEDLER S, SCHENKER JG, HERMANN A, LEWIN A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update 2:323-325, 1996. GEYTER CD, SCHMITTER M, GEYTER MD, NIESCHLAG E, HOLZGLEVE W, SCHNEIDER H. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril 73:106-113, 2000. GONEN Y, CASPER RF, JACOBSON W, BLANKIER J. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertile Steril 52:446-450, 1989. KHALIFA E, BRZYSKI RG, OEHNINGER S, ACOSTA AA, MUASHER SJ. Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles. Human Reprod 7:677-680, 1992. KOVACS P, MATYAS Sz, BODA K, KAALI S.G. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod 18: 2337-2341, 2003 NOYES N, LIU HC, SULTAN K, SCHATTMAN G, ROSENWAKS Z. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertolization. Hum Reprod 10: 919-922, 1995 REMOHI J, ARDILES G, GARCIA-VELASCO JA, PILAR GAITAN P, SIMON C, PELLICER A. Endometrial thickness and serum oestradiol concentration as predictors of outcome in oocyte donation. Human Reprod 12:2271-2276, 1997. REUTER KL, COHEN S, FUREY L, BAKER S. Sonographic appearance of the endometrium and ovaries during cycles stimulated with human menopausal gonadotropin. J Reprod Med 41:509-514, 1996. RINALDI L, LISI F, FLOCCARI A, LISI R, PEPE G, FISHEL S. Endometrial thickness as a predictor of pregnancy after in-vitro fertilization but not after intracytoplasmic sperm injection. Hum Reprod 11 1538-1541 RUIZ-VELASCO V, ALFANI GG, SANCHEZ LP, MARCELA VA. Endometrial pathology and infertility. Fertil Steril 67:687-692, 1997. SUNDSTORM P. Establishment of a successful pregnancy following in-vitro fertilization with an endometrial thickness of no more than 4mm. Hum Reprod 13:1550-1552, 1998. VEECK LL. Oocyte assessment and biological performance. Ann N Y Acad Sci 541:259-274, 1988. YUVAL Y, LIPITZ S, DOR J, ACHIRON R. The relationships between endometrial thickness and blood flow and pregnancy rates in in-vitro fertilization. Hum Reprod 14: 1067-1071, 1999 Received 22 January, 2003 Accepted 5 February, 2004 Bulletin of the Osaka Medical College 49 1, 2 5-9, 2003 9